TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%

Bulletin Express06-18

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.

Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.

The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103580602?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103580602","market":"hk","top_or_hot":-1,"title":"TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.</p>\n<p>Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.</p>\n<p>The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-18 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.</p>\n<p>Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.</p>\n<p>The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1103580602","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103580602","pubTimestamp":1781773554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药回购54万股A股，自由流通量削减0.08%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.\nFollowing the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.\nThe shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103580602","isCrawlerRequest":true}